InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2024-07-05 00:00:00 ET · period of report 2024-07-01 · accession 0001127602-24-020165 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-07-05 2024-07-02 DNA Coen Steven P. See remarks S - Sale+OE $0.33 -13.5K 195.1K -6% -$4,462
DM 2024-07-05 2024-07-01 DNA Coen Steven P. See remarks M - OptEx — +29.7K 202.3K +17% —
DM 2024-07-05 2024-07-01 DNA Coen Steven P. See remarks M - OptEx — -29.7K 275.0K -10% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-07-02 S D 13,520 $0.33 195,058 D — —
2 Common Class A Common Stock 2024-07-01 M A 6,250 — 208,578 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
3 Common Class A Common Stock 2024-07-01 M A 23,496 — 202,328 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Derivative Restricted Stock Units 2024-07-01 M D 23,496 — 798,873 D — · — to — 23,496 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
5 Derivative Restricted Stock Units 2024-07-01 M D 6,250 — 275,001 D — · — to — 6,250 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.